Toxicological Evaluation and In Silico Identification of Acetylcholinesterase Inhibitors in a Commercial Polyherbal Formulation (KWAPF01)

Table 1

Secondary metabolites in KWAPF01 formulation.

Peaks	Compounds	Molecular formula	Molecular weight (g/mol)	Retention time	%Peak area
1	Catechol	C6H4(OH)2	110.11	1.27	7.15
2	Chrysin	C15H10O4	254.24	2.52	11.05
3	Terminalin-A	C30H52O2	444.70	4.45	3.10
4	Galangin	C15H10O5	270.24	5.47	1.31
5	Berberine	C20H18NO4^+	336.36	6.48	0.85
6	Nicotine	C10H14N2	162.24	11.05	41.21
7	Arjungenin	C30H48O6	504.70	12.17	16.47
8	Friedelin	C30H50O	426.70	13.70	15.22
9	Apigenin	C15H10O5	270.05	16.25	0.59
10	Cryptolepine	C16H12N2	232.29	17.62	2.60
11	11-Methoxy-10H-quindoline	C16H12N2O	248.28	19.68	0.46